RN

Robert J. Naylor

AI A. H. Robins Company, Incorporated: 3 patents #21 of 80Top 30%
Overall (All Time): #429,491 of 4,157,543Top 15%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
5206246 Anxiolytic-R-n(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides Michel Langlois, Alain Renaud, Brenda Naylor 1993-04-27
5141949 Method of providing anxiolytic and antipsychotic treatment Jacques Acher, Jean-Claude Monier, Jean-Paul Schmitt, Brenda Costall, Renee Gardaix-Luthereau 1992-08-25
5116857 Method of increasing gastrointestinal motility with substituted benzamides Jacques Acher, Jean-Claude Monier, Jean-Paul Schmitt, Brenda Costall, Renee Gardaix-Luthereau 1992-05-26
5116859 Method of providing anxiolytic and antipsychotic treatment Jacques Acher, Jean-Claude Monier, Jean-Paul Schmitt, Brenda Costall, Renee Gardaix-Luthereau 1992-05-26
5110824 Method of treating disorders of cognitive function with substituted benzamides Jacques Acher, Jean-Claude Monier, Jean-Paul Schmitt, Renee Gardaix-Luthereau, Brenda Costall 1992-05-05
5086066 Method of providing anxiolytic and antipsychotic treatment with substituted benzamides Jacques Acher, Jean-Claude Monier, Jean-Paul Schmitt, Renee Gardaix-Luthereau, Brenda Costall 1992-02-04
5025022 Method of treating or preventing schizophrenia and/or psychosis using S-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides Brenda Naylor, Alain Renaud, Michel Langlois 1991-06-18
5017580 Memory enhancing-R-N-(1-azabicyclo[2.2.2.]oct-3-yl)benzamides and thiobenzamides Brenda Naylor, Alain Renaud, Michel Langlois 1991-05-21
4908370 Anxiolytic-n-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides Brenda Naylor 1990-03-13
4877794 2-Alkoxy-n-(1-azabicyclo(2.2.2)oct-3-yl) benzamide and thiobenzamide compositions and the use thereof to treat schizophrenia Brenda Naylor 1989-10-31
4835172 Novel benzamides, intermediates and process for the preparation and therapeutic use thereof Jacques Acher, Jean-Claude Monier, Jean-Paul Schmitt, Renee Gardaix-Luthereau, Brenda Costall 1989-05-30
4725618 Use of N-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulphamoyl benzamide in the treatment of Parkinson's disease Denis Besancon, Brenda Costall, Peter Jenner, Charles D. Marsden 1988-02-16